Lower riskDrug recall · FDA · Published May 19, 2020
American Health Doxycycline Tablets Recall: Failed Dissolution at Shelf Life
American Health Packaging recalls 100mg Doxycycline Hyclate Tablets due to failed dissolution testing at 24 months. This may affect medication effectiveness. Check NDC codes and expiration dates for affected lots.
“American Health Doxycycline Tablets Recall: Failed Dissolution at Shelf Life.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37115-american-health-doxycycline-tablets-recall-failed-dissolution-at-shelf-life. Based on FDA recall #D-1293-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1293-2020%22&limit=1).
American Health Packaging voluntarily recalled Doxycycline Hyclate Tablets, USP, 100 mg because they failed dissolution specifications at the end of shelf life, according to the FDA. The Food and Drug Administration announced the Class II recall on May 19, 2020.
How to tell if you have it
Brand: American Health Packaging
Product: Doxycycline Hyclate Tablets, USP, 100 mg, 30 Tablets per carton (3 x 10)
NDC Carton: 62584-693-21
NDC Unit Dose: 62584-693-11
Lot 179605, Exp 06/30/2020
Lot 181105, Exp 08/31/2020
Lot 183019, Exp 01/31/2021
Distribution: USA Nationwide
The hazard
The recall addresses failed dissolution specifications, with results showing only 59% dissolution at the 24-month time point compared to the required not less than 85%. The FDA stated this issue occurs at the end of shelf life.
Context
GovInfoNow's records show American Health Packaging has 41 other recalls on record since July 23, 2012. Other recent recalls include a Buprenorphine Tablets recall for label mix-up hazards on Aug. 19, 2026, and a Nitrofurantoin Capsules recall for failed dissolution specifications on May 3, 2022. Similar recent recalls of similar products include Ascend Minocycline Tablets for failed dissolution test risk on June 1, 2026, Inventia Chlorthalidone for failed dissolution specs on Sept. 3, 2026, and Golden State NIACIN Extended-Release Tablets for failed dissolution testing on May 29, 2026.
How to tell if you have this one
Check for NDC Carton 62584-693-21 or NDC Unit Dose 62584-693-11. The affected lots are 179605 (expiring 06/30/2020), 181105 (expiring 08/31/2020), and 183019 (expiring 01/31/2021).
Brand
American Health Packaging
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Verify the NDC codes and expiration dates on your medication packaging to confirm if it's in the recalled lots.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.2 years after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1293-2020 (May 19, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1293-2020 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.